federal_register: 2023-27304
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-27304 | Advisory Committee; Genetic Metabolic Diseases Advisory Committee; Establishment | Notice | Under the Federal Advisory Committee Act, the Food and Drug Administration (FDA) is announcing the establishment of the Genetic Metabolic Diseases Advisory Committee. The Commissioner of Food and Drugs (Commissioner) has determined that it is in the public interest to establish such a committee. Duration of this committee is 2 years from the date the Charter is filed, unless the Commissioner formally determines that renewal is in the public interest. | 2023-12-13 | 2023 | 12 | https://www.federalregister.gov/documents/2023/12/13/2023-27304/advisory-committee-genetic-metabolic-diseases-advisory-committee-establishment | https://www.govinfo.gov/content/pkg/FR-2023-12-13/pdf/2023-27304.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | Under the Federal Advisory Committee Act, the Food and Drug Administration (FDA) is announcing the establishment of the Genetic Metabolic Diseases Advisory Committee. The Commissioner of Food and Drugs (Commissioner) has determined that it is in the... |